In pursuance to Regulation 25(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and terms of the provision of Section 173 and Schedule IV of the Companies Act, 2013, Triochem Products has informed that a separate meeting of the Independent Directors of the company was held today Friday, 20th March 2026 at 3.00 pm at the registered office of the company at 4th Floor, Sambava Chambers, Sir P. M. Road, Fort, Mumbai: 400001, wherein, the following items in agenda were considered and discussed: 1. Review the performance of Non-Independent Directors and the Board as a whole. 2. Review the performance of the chairperson of the company. 3. Assessed the Quality, Quantity, and timeliness of the flow of information between the company management and the Board that is necessary for the Board to perform their duties effectively and reasonably. The meeting commenced at 3.00 pm and ended at 4.10 pm.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: